trimethoprim has been researched along with Leprosy, Borderline in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Leprosy, Borderline: A form of LEPROSY in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haas, M | 1 |
| Lindner, B | 1 |
| Dietz, M | 1 |
| Tebebe, YB | 1 |
| Seydel, U | 1 |
1 other study available for trimethoprim and Leprosy, Borderline
| Article | Year |
|---|---|
Determination of in vivo and in vitro drug effects of mycobacteria from the mass spectrometric analysis of single organisms.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Isoniazid; Leprostatic Agents; Leprosy, B | 1991 |